One recent study showed that Gemifloxacin possess anti-metastatic activities against breast cancer in vitro and in vivo (in mice).
wˈʌn ɹˈiːsənt stˈʌdi ʃˈoʊd ðæt dʒˈɛmɪflˌɑːksɐsˌɪn pəzˈɛs ˈæntaɪmˌɛɾəstˈæɾɪk æktˈɪvᵻɾiz ɐɡˈɛnst bɹˈɛst kˈænsɚɹ ɪn vˈɪtɹoʊ ænd ɪn vˈiːvoʊ ɪn mˈaɪs.